The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer (2014)

Peer-Reviewed Study · Melotti A, Mas C, Kuciak M, Lorente-Trigos A, Borges I, Ruiz i Altaba A · October 2014

Melotti A et al., 2014-10: A Geneva group reports ivermectin blocks WNT-TCF signalling and inhibits growth of TCF-dependent xenografts, and flags selamectin as more potent.

In vivo, Ivermectin selectively inhibits TCF-dependent, but not TCF-independent, xenograft growth without obvious side effects.

1263

Melotti A et al., 2014-10: A Geneva group reports ivermectin blocks WNT-TCF signalling and inhibits growth of TCF-dependent xenografts, and flags selamectin as more potent. Study type: lab.